Novo Nordisk partners with Anthropic on Claude for drug discovery

The collaboration deploys Anthropic frontier models and Claude Science into Novo’s R&D workflows to accelerate medicine discovery and AI-driven software development. It marks a concrete enterprise adoption of frontier AI in high-stakes pharmaceutical research under defined data governance and human oversight. The partnership expands real-world deployment of advanced models beyond general productivity into regulated scientific domains.